[Betadrenol in the hyperkinetic heart syndrome and functional heart disorders].
作者信息
Vorberg G
出版信息
MMW Munch Med Wochenschr. 1978 Jan 20;120(2-3):77-8.
PMID:23494
Abstract
摘要
相似文献
1
[Betadrenol in the hyperkinetic heart syndrome and functional heart disorders].[β-肾上腺素能药物在运动亢进性心脏综合征及功能性心脏疾病中的应用]
MMW Munch Med Wochenschr. 1978 Jan 20;120(2-3):77-8.
2
[Therapeutic problems in hyperkinetic heart syndrome].
Acta Med Austriaca. 1984;11(1):17-22.
3
[The antihypertensive effect of a new beta-adrenergic blocking drug metroprolol in combination with chlorthalidone].
Duodecim. 1976;92(11):597-603.
4
Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).新型β受体阻滞剂GYKI-41099（托巴奴）的临床药理学评价
Int J Clin Pharmacol Ther Toxicol. 1980;18(5):200-7.
5
Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent.新型β-肾上腺素能阻滞剂ICI66.082的降压作用
Int J Clin Pharmacol. 1974 Oct;10(3):206-11.
6
[Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension].
Ugeskr Laeger. 1975 Sep 22;137(39):2274-6.
7
[Intraindividual comparison of 2 bisoprolol dosages in patients with essential hypertension].
Med Klin (Munich). 1986 Apr 25;81(9):307-10.
8
[Effects in humans of a new beta adrenergic receptor blocking agent on tachycardia induced with isoprenaline].
Minerva Cardioangiol. 1973 Dec 12;21(12):854-9.
9
Tobanum treatment in mild and medium severity hypertension.
Ther Hung. 1986;34(3):171-4.
10
[Use of Cordanum in labile hypertension].
Vrach Delo. 1982 Nov(11):29-30.
Zotero 插件